Samlyn Capital, LLC Envista Holdings Corp Transaction History

Samlyn Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$35.59 - $48.1 $13.3 Million - $18 Million	-374,926 Reduced 16.17%	1,944,155 $74.9 Million
Q1 2022 May 16, 2022	BUY	$41.4 - $50.9 $51.2 Million - $63 Million	1,237,413 Added 114.4%	2,319,081 $113 Million
Q4 2021 Feb 14, 2022	SELL	$37.73 - $46.74 $5.66 Million - $7.01 Million	-149,924 Reduced 12.17%	1,081,668 $48.7 Million
Q3 2021 Nov 15, 2021	BUY	$39.75 - $44.09 $9.38 Million - $10.4 Million	236,065 Added 23.71%	1,231,592 $51.5 Million
Q2 2021 Aug 16, 2021	BUY	$40.83 - $45.48 $40.6 Million - $45.3 Million	995,527 New	995,527 $43 Million
Q1 2020 May 15, 2020	SELL	$11.91 - $33.2 $11.6 Million - $32.2 Million	-970,994 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$26.78 - $30.67 $26 Million - $29.8 Million	970,994 New	970,994 $28.8 Million

315

200M

128K

52.4K

Ticker NVST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 163,391,008
Market Cap $3.13B
Description
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.